The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LXXIII.—Oxidation of tartaric acid in presence of iron
Fenton, H. J. H. (1894) · J. Chem. Soc., Trans. · doi:10.1039/ct8946500899 · Cited by 3,179
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Oxidation of tartaric acid in presence of iron
Fenton, H. J. H. (1894) · Journal of the Chemical Society (Resumed) · Cited by 1,498
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“In a mouse model of AD, clioquinol decreased brain beta amyloid deposition.(91) Based on the strength of the data, a pilot study of clioquinol in patients with AD was performed.”
BackgroundThe effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Imaging iron stores in the brain using magnetic resonance imaging
Haacke, E. M., Cheng, N. Y. C., House, M. J., Liu, Q., Neelavalli, J., Ogg, R. J., Khan, A., Ayaz, M., Kirsch, W., & Obenaus, A. (2005) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2004.10.001 · Cited by 995
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
In vivo measurement of T2 distributions and water contents in normal human brain
Whittall, K. P., Mackay, A. L., Graeb, D. A., Nugent, R. A., Li, D. K. B., & Paty, D. W. (1997) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910370107 · Cited by 793
Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777
Intramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 752
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux
Harris, Z. L., Durley, A. P., Man, T. K., & Gitlin, J. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10812 · Cited by 568
Levites, Y., Weinreb, O., Maor, G., Youdim, M. B. H., & Mandel, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00490.x · Cited by 567
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Iron Metabolism and the IRE/IRP Regulatory System: An Update
PANTOPOULOS, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.001 · Cited by 512
Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells
Crichton, R. R., Wilmet, S., Legssyer, R., & Ward, R. J. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00461-0 · Cited by 495
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472
Mantyh, P. W., Ghilardi, J. R., Rogers, S., DeMaster, E., Allen, C. J., Stimson, E. R., & Maggio, J. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03639.x · Cited by 465
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411
Advances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 394
Redox-active iron mediates amyloid-β toxicity
Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C. S., Chevion, M., Perry, G., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00494-9 · Cited by 375
Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310214 · Cited by 374
Gelman, N., Gorell, J. M., Barker, P. B., Savage, R. M., Spickler, E. M., Windham, J. P., & Knight, R. A. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe41759 · Cited by 373
Drayer, B., Burger, P., Darwin, R., Riederer, S., Herfkens, R., & Johnson, G. (1986) · American Journal of Roentgenology · doi:10.2214/ajr.147.1.103 · Cited by 365
Vymazal, J., Righini, A., Brooks, R. A., Canesi, M., Mariani, C., Leonardi, M., & Pezzoli, G. (1999) · Radiology · doi:10.1148/radiology.211.2.r99ma53489 · Cited by 342
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration
Bartzokis, G., Tishler, T. A., Lu, P. H., Villablanca, P., Altshuler, L. L., Carter, M., Huang, D., Edwards, N., & Mintz, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.005 · Cited by 341
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
Ke, Y., & Qian, Z. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00353-3 · Cited by 340
A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury
Marshall, L. F., Maas, A. I. R., Marshall, S. B., Bricolo, A., Fearnside, M., Iannotti, F., Klauber, M. R., Lagarrigue, J., Lobato, R., Persson, L., et al. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.4.0519 · Cited by 336
Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020710.x · Cited by 334
Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease
Gorell, J. M., Ordidge, R. J., Brown, G. G., Deniau, J.-C., Buderer, N. M., & Helpern, J. A. (1995) · Neurology · doi:10.1212/wnl.45.6.1138 · Cited by 324
Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla
Ordidge, R. J., Gorell, J. M., Deniau, J. C., Knight, R. A., & Helpern, J. A. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320309 · Cited by 323
Aktas, O., Prozorovski, T., Smorodchenko, A., Savaskan, N. E., Lauster, R., Kloetzel, P.-M., Infante-Duarte, C., Brocke, S., & Zipp, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5794 · Cited by 316
The possible role of iron in the etiopathology of parkinson's disease
Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. (1993) · Movement Disorders · doi:10.1002/mds.870080102 · Cited by 301
Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11444.x · Cited by 299
Balla, G., Vercellotti, G. M., Müller‐Eberhard, U., Eaton, J. W., & Jacob, H. S. (1991) · PubMed · Cited by 298
Youdim, M. B. H., Ben-Shachar, D., & Riederer, P. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01782.x · Cited by 292
Theory and application of static field inhomogeneity effects in gradient‐echo imaging
Reichenbach, J. R., Venkatesan, R., Yablonskiy, D. A., Thompson, M. R., Lai, S., & Haacke, E. M. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070203 · Cited by 285
Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease
Duffy, S. J., Biegelsen, E. S., Holbrook, M., Russell, J. D., Gokce, N., Keaney, J. F., & Vita, J. A. (2001) · Circulation · doi:10.1161/01.cir.103.23.2799 · Cited by 271
Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin
Levi, S., Yewdall, S. J., Harrison, P. M., Santambrogio, P., Cozzi, A., Rovida, E., Albertini, A., & Arosio, P. (1992) · Biochemical Journal · doi:10.1042/bj2880591 · Cited by 268
Decreased ferritin levels in brain in Parkinson's disease
Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258
Iron deposits in multiple sclerosis and Alzheimer's disease brains
LeVine, S. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00470-8 · Cited by 258
Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain.
Cornett, C., Markesbery, W. R., & Ehmann, W. D. (1998) · PubMed · Cited by 251
Shachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246
In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging
Bartzokis, G., Sultzer, D., Cummings, J., Holt, L. E., Hance, D. B., Henderson, V. W., & Mintz, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.47 · Cited by 235
Bakshi, R., Benedict, R. H. B., Bermel, R. A., Caruthers, S. D., Puli, S. R., Tjoa, C. W., Fabiano, A. J., & Jacobs, L. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.62 · Cited by 234
Self-citationAntioxidant Treatment of Patients With Friedreich Ataxia: Four-Year Follow-up
Hart, P. E., Lodi, R., Rajagopalan, B., Bradley, J. L., Crilley, J. G., Turner, C., Blamire, A. M., Manners, D., Styles, P., Schapira, A. H. V., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.4.621 · Cited by 225
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
Graham, J. M. (2000) · Brain · doi:10.1093/brain/123.12.2423 · Cited by 223
Zecca, L., Berg, D., Arzberger, T., Ruprecht, P., Rausch, W. D., Musicco, M., Tampellini, D., Riederer, P., Gerlach, M., & Becker, G. (2005) · Movement Disorders · doi:10.1002/mds.20550 · Cited by 214
MRI evaluation of brain iron in earlier- and later-onset Parkinson’s disease and normal subjects
Bartzokis, G., Cummings, J. L., Markham, C. H., Marmarelis, P. Z., Treciokas, L. J., Tishler, T. A., Marder, S. R., & Mintz, J. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00155-6 · Cited by 212
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation
Chinnery, P. F., Crompton, D. E., Birchall, D., Jackson, M. J., Coulthard, A., Lombes, A., Quinn, N., Wills, A., Fletcher, N., Mottershead, J. P., et al. (2006) · Brain · doi:10.1093/brain/awl319 · Cited by 205
Oxidative stress as a cause of Parkinson's disease
Jenner, P., & Jenner, P. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05013.x · Cited by 205
Oxidative Stress and Redox‐Active Iron in Alzheimer's Disease
HONDA, K., CASADESUS, G., PETERSEN, R. B., PERRY, G., & SMITH, M. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.015 · Cited by 204
Bartzokis, G., & Tishler, T. A. (2000) · PubMed · Cited by 197
Iron deposits surrounding multiple sclerosis plaques.
Craelius, W., Mw, M., Luessenhop, C. P., Sugar, A. W., & Mihalakis, I. (1982) · PubMed · Cited by 197
Brain trace elements in Alzheimer's disease.
Ehmann, W. D., Markesbery, W. R., Alauddin, M., Hossain, T. I., & Brubaker, E. H. (1986) · PubMed · Cited by 192
Lee, J.-Y., Friedman, J. E., Angel, I., Kozak, A., & Koh, J.-Y. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.005 · Cited by 191
Iron and oxygen radicals in brain
Gutteridge, J. M. C. (1992) · Annals of Neurology · doi:10.1002/ana.410320705 · Cited by 190
Magnetic Resonance Imaging of Iron Deposition in Neurological Disorders
Brass, S. D., Chen, N.-K., Mulkern, R. V., & Bakshi, R. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245459.82782.e4 · Cited by 189
Self-citationBrain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases
BARTZOKIS, G., TISHLER, T. A., SHIN, I., LU, P. H., & CUMMINGS, J. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.019 · Cited by 186
Iron metabolism in Parkinsonian syndromes
Berg, D., & Hochstrasser, H. (2006) · Movement Disorders · doi:10.1002/mds.21020 · Cited by 186
Gal, S., Zheng, H., Fridkin, M., & Youdim, M. B. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03341.x · Cited by 185
MR evaluation of age-related increase of brain iron in young adult and older normal males
Bartzokis, G., Beckson, M., Hance, D. B., Marx, P., Foster, J. A., & Marder, S. R. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(96)00234-2 · Cited by 181
Isoforms of ferritin have a specific cellular distribution in the brain
Connor, J. R., Boeshore, K. L., Benkovic, S. A., & Menzies, S. L. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370405 · Cited by 179
Liu, G., Men, P., Harris, P. L. R., Rolston, R. K., Perry, G., & Smith, M. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.020 · Cited by 178
Drayer, B., Burger, P., Hurwitz, B., Dawson, D., & Cain, J. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.357 · Cited by 178
Use of desferrioxamine in the treatment of aceruloplasminemia
Miyajima, H., Takahashi, Y., Kamata, T., Shimizu, H., Sakai, N., & Gitlin, J. D. (1997) · Annals of Neurology · doi:10.1002/ana.410410318 · Cited by 173
The relation between brain iron and NMR relaxation times: An in vitro study
Vymazal, J., Brooks, R. A., Baumgarner, C., Tran, V., Katz, D., Bulte, J. W. M., Bauminger, E. R., & Chiro, G. D. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910350108 · Cited by 172
Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores
Bartzokis, G., Aravagiri, M., Oldendorf, W. H., Mintz, J., & Marder, S. R. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910290406 · Cited by 172
T 2 relaxation time in patients with Parkinson's disease
Antonini, A., Leenders, K. L., Meier, D., Oertel, W. H., Boesiger, P., & Anliker, M. (1993) · Neurology · doi:10.1212/wnl.43.4.697 · Cited by 168
Superficial siderosis: a case report and review of the literature
Levy, M., Turtzo, C., & Llinas, R. H. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0356 · Cited by 166
Ceruloplasmin in neurodegenerative diseases
Vassiliev, V. B., Harris, Z. L., & Zatta, P. F. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.003 · Cited by 166
A Randomized Trial of Tirilazad Mesylate in Patients With Acute Stroke (RANTTAS)
(1996) · Stroke · doi:10.1161/01.str.27.9.1453 · Cited by 165
Idebenone treatment in Friedreich’s ataxia: Neurological, cardiac, and biochemical monitoring
Buyse, G., Mertens, L., Di Salvo, G., Matthijs, I., Weidemann, F., Eyskens, B., Goossens, W., Goemans, N., Sutherland, G. R., & Van Hove, J. L. K. (2003) · Neurology · doi:10.1212/01.wnl.0000068549.52812.0f · Cited by 161
Aceruloplasminemia: An Inherited Neurodegenerative Disease with Impairment of Iron Homeostasis
XU, X., PIN, S., GATHINJI, M., FUCHS, R., & HARRIS, Z. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.024 · Cited by 160
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice
Lan, J., & Jiang, D. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277665 · Cited by 159
Brass, S. D., Benedict, R. H., Weinstock-Guttman, B., Munschauer, F., & Bakshi, R. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1301oa · Cited by 158
Self-citationMa, J., & Wehrli, F. W. (1996) · Journal of Magnetic Resonance Series B · doi:10.1006/jmrb.1996.0060 · Cited by 157
Ruuls, S. R., Bauer, J., Sontrop, K., Huitinga, I., Hart, B. A. ‘., & Dijkstra, C. D. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00154-g · Cited by 153
Hereditary Ferritinopathy: A Novel Mutation, Its Cellular Pathology, and Pathogenetic Insights
Mancuso, M., Davidzon, G., Kurlan, R., Tawil, R., Bonilla, E., Mauro, S. D., & Powers, J. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.280 · Cited by 151
Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children.
Dietrich, R. B., & Bradley, W. G. (1988) · Radiology · doi:10.1148/radiology.168.1.3380958 · Cited by 151
The pathogenesis of superficial siderosis of the central nervous system
Koeppen, A. H., Dickson, A. C., Chu, R. C., & Thach, R. E. (1993) · Annals of Neurology · doi:10.1002/ana.410340505 · Cited by 149
Cameron, N. E., & Cotter, M. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118104 · Cited by 147
Marracci, G., Jones, R. E., McKeon, G. P., & BOURDETTE, D. N. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00269-2 · Cited by 144
Dextran-Coupled Deferoxamine Improves Outcome in a Murine Model of Head Injury
Panter, S. S., Braughler, J. M., & Hall, E. D. (1992) · Journal of Neurotrauma · doi:10.1089/neu.1992.9.47 · Cited by 144
Self-citationMichaeli, S., Öz, G., Sorce, D. J., Garwood, M., Uǧurbil, K., Majestic, S., & Tuite, P. (2006) · Movement Disorders · doi:10.1002/mds.21227 · Cited by 141
Zucca, F. A., Bellei, C., Giannelli, S. G., Terreni, M., Gallorini, M., Rizzio, E., Pezzoli, G., Albertini, A., & Zecca, L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0453-2 · Cited by 138
A proposed dual role of neuromelanin in the pathogenesis of Parkinson’s disease
Zecca, L., Zucca, F. A., Albertini, A., Rizzio, E., & Fariello, R. G. (2006) · Neurology · doi:10.1212/wnl.67.7_suppl_2.s8 · Cited by 138
In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI
Bartzokis, G., Sultzer, D. L., Mintz, J., Holt, L. E., Marx, P., Phelan, C., & Marder, S. R. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90047-7 · Cited by 136
MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease
Kosta, P., Argyropoulou, M. I., Markoula, S., & Konitsiotis, S. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0914-9 · Cited by 135
Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
Hayflick, S. J., Hartman, M., Coryell, J. C., Gitschier, J. M., & Rowley, H. A. (2006) · PubMed · Cited by 135
Uitti, R. J., Rajput, A. H., Rozdilsky, B., Bickis, M., Wollin, T., & Yuen, W. K. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029140 · Cited by 135
Mehindate, K., Sahlas, D. J., Frankel, D., Mawal, Y., Liberman, A., Corcos, J., Dion, S., & Schipper, H. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00354.x · Cited by 129
Neema, M., Stankiewicz, J., Arora, A., Dandamudi, V. S. R., Batt, C. E., Guss, Z. D., AL-Sabbagh, A., & Bakshi, R. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00131.x · Cited by 124
Self-citationMoos, T. (2002) · PubMed · Cited by 123
Potential sources of increased iron in the substantia nigra of parkinsonian patients
Gerlach, M., Double, K. L., Youdim, M. B. H., & Riederer, P. F. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_21 · Cited by 122
Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid
Moos, T., & Morgan, E. H. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981115)54:4<486::aid-jnr6>3.0.co;2-i · Cited by 122
Dedman, D., Treffry, A., Candy, J., Taylor, G. A., Morris, C. M., Bloxham, C. A., Perry, R. H., Edwardson, J. A., & Harrison, P. M. (1992) · Biochemical Journal · doi:10.1042/bj2870509 · Cited by 121
A non-essential function for yeast frataxin in iron-sulfur cluster assembly
Duby, G. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2635 · Cited by 120
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent.
Bowern, N., Ramshaw, I. A., Clark, I. A., & Doherty, P. C. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1532 · Cited by 119
Hayflick, S. J. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200312000-00005 · Cited by 119
Heme Oxygenase‐1: Transducer of Pathological Brain Iron Sequestration under Oxidative Stress
Schipper, H. M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.007 · Cited by 117
Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders
Hall, E. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320724 · Cited by 117
Oxidative Stress, Mitochondrial Respiration, and Parkinson's Disease
Cohen, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06180.x · Cited by 116
Magnetic resonance imaging of brain iron
Schenck, J. F. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00431-8 · Cited by 116
The physiopathological significance of ceruloplasmin
Floris, G., Medda, R., Padiglia, A., & Musci, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00399-3 · Cited by 116
Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study
Gałązka-Friedman, J., Bauminger, E. R., Friedman, A., Barcikowska, M., Hechel, D., & Nowik, I. (1996) · Movement Disorders · doi:10.1002/mds.870110104 · Cited by 113
Rouault, T. A. (2001) · Nature Genetics · doi:10.1038/91036 · Cited by 112
Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights
Loréal, O., Turlin, B., Pigeon, C., Moisan, A., Ropert, M., Morice, P., Gandon, Y., Jouanolle, A., Vérin, M., Hider, R. C., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00042-9 · Cited by 110
Nielsen, J. E., Jensen, L. N., & Krabbe, K. S. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.318 · Cited by 108
T2 values in the human brain: comparison with quantitative assays of iron and ferritin.
Chen, J. C., Hardy, P., Clauberg, M., Joshi, J. G., Parravano, J. G., Deck, J. H. N., Henkelman, R. M., Becker, L. E., & Kucharczyk, W. (1989) · Radiology · doi:10.1148/radiology.173.2.2798884 · Cited by 108
House, M. J., Pierre, T. G. S., Kowdley, K. V., Montine, T. J., Connor, J. R., Beard, J., Berger, J., Siddaiah, N. B., Shankland, E. G., & Jin, L. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21118 · Cited by 107
Richardson, D. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.026 · Cited by 107
Hereditary Causes of Disturbed Iron Homeostasis in the Central Nervous System
Ponka, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.022 · Cited by 106
Tjoa, C. W., Benedict, R. H. B., Weinstock‐Guttman, B., Fabiano, A. J., & Bakshi, R. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.02.009 · Cited by 104
Self-citationBermel, R. A., Puli, S. R., Rudick, R. A., Weinstock‐Guttman, B., Fisher, E., Munschauer, F. E., & Bakshi, R. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.1371 · Cited by 99
Self-citationSavoiardo, M. (2003) · Neurological Sciences · doi:10.1007/s100720300036 · Cited by 97
An MRI method for measuring T 2 in the presence of static and RF magnetic field Inhomogeneities
Yablonskiy, D. A., & Haacke, E. M. (1997) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910370611 · Cited by 95
Thomas, L. E., Boyko, O. B., Anthony, D. C., & Burger, P. C. (1993) · PubMed Central · Cited by 95
High-Dose Tirilazad for Acute Stroke (RANTTAS II)
Haley, E. C. (1998) · Stroke · doi:10.1161/str.29.6.1256/a · Cited by 94
MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation
Bakshi, R., Shaikh, Z. A., & Janardhan, V. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00004 · Cited by 92
Self-citationCorrelation of R2 with total iron concentration in the brains of rhesus monkeys
Hardy, P., Gash, D. M., Yokel, R. A., Andersen, A. H., Ai, Y., & Zhang, Z. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20244 · Cited by 92
Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss.
House, M. J., Pierre, T. G. S., Foster, J. K., Martins, R. N., & Clarnette, R. (2006) · UWA Profiles and Research Repository (University of Western Australia) · Cited by 91
Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths
Schenck, J. F. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00203-e · Cited by 90
Pulliam, J. F., Jennings, C. D., Kryscio, R. J., Davis, D. G., Wilson, D., Montine, T. J., Schmitt, F. A., & Markesbery, W. R. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10069 · Cited by 89
Biological Significance of Iron-Related Magnetic Resonance Imaging Changes in the Brain
Pujol, J., Junqué, C., Vendrell, P., Grau, J. M., Martí-Vilalta, J. L., Olivé, C., & Gili, J. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530310053012 · Cited by 89
Shin, R., Kruck, T. P. A., Murayama, H., & Kitamoto, T. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03893-3 · Cited by 88
Blood Letting in High-Ferritin Type 2 Diabetes
Fernández‐Real, J. M., Peñarroja, G., Castro, A., Garcia-Bragado, F., López‐Bermejo, A., & Ricart, W. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2249 · Cited by 87
Malfroy, B., Doctrow, S. R., Orr, P. L., Tocco, G., Fedoseyeva, E. V., & Bénichou, G. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1091 · Cited by 86
Deferoxamine improves spatial memory performance following experimental brain injury in rats
Long, D. A., Ghosh, K., Moore, A. N., Dixon, C. E., & Dash, P. K. (1996) · Brain Research · doi:10.1016/0006-8993(95)01500-0 · Cited by 85
Magnetic field correlation imaging
Jensen, J. H., Chandra, R., Ramani, A., Lu, H., Johnson, G., Lee, P., Kaczynski, K., & Helpern, J. A. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20907 · Cited by 85
Liddell, J. R., Hoepken, H. H., Crack, P. J., Robinson, S. R., & Dringen, R. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20957 · Cited by 83
Palatal tremor and cognitive decline in neuroferritinopathy
Wills, A. J. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.1.91 · Cited by 79
Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice
Pedchenko, T. V., & LeVine, S. M. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00256-7 · Cited by 78 · cited 2×
“Postulating that DES scavenges and prevents free radical formation, and consequently will only be efficacious during active disease, Pedchenko et al.(119) treated rats in the active stage of EAE and observed significantly reduced clinical signs when compared to vehicle-treated animals.”
ResultThe basal ganglia in haemochromatosis
小川, 妙., Hoggenmüller, U., Hofmann, E., Fischer, R., Kraus, M., Scheurlen, M., & Becker, G. (2000) · Neuroradiology · doi:10.1007/s002340050002 · Cited by 75
Magnetic Resonance Imaging of Corticobasal Degeneration
Hauser, R. A., Murtagh, F. R., Akhter, K., Gold, M., & Olanow, C. W. (1996) · Journal of Neuroimaging · doi:10.1111/jon199664222 · Cited by 72
Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T.
Milton, W. J., Atlas, S. W., Lexa, F. J., Mozley, P. D., & Gur, R. E. (1991) · Radiology · doi:10.1148/radiology.181.3.1947087 · Cited by 72
Rosenthal, R. E., Chanderbhan, R. F., Marshall, G., & Fiskum, G. M. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90055-l · Cited by 71
MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images
Kamran, S., & Bakshi, R. (1998) · Neuroradiology · doi:10.1007/s002340050637 · Cited by 69
Self-citationIron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys
Cass, W. A., Grondin, R., Andersen, A. H., Zhang, Z., Hardy, P. A., Hussey-Andersen, L. K., Rayens, W. S., Gerhardt, G. A., & Gash, D. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.010 · Cited by 67
The free radical hypothesis in idiopathic parkinsonism: Evidence against it
Calne, D. B. (1992) · Annals of Neurology · doi:10.1002/ana.410320615 · Cited by 65
Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate
Kuhn, J., Bewermeyer, H., Miyajima, H., Takahashi, Y., Kuhn, K. F., & Hoogenraad, T. U. (2007) · Brain and Development · doi:10.1016/j.braindev.2007.01.001 · Cited by 62
Hemeoxygenase-1 in SJL mice with experimental allergic encephalomyelitis
Chakrabarty, A., Emerson, M. R., & LeVine, S. M. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms928oa · Cited by 60
Atasoy, H. T., Nuyan, O., Tunç, T., et al. (2004) · PubMed · Cited by 60
T 2 relaxation rate of basal ganglia and cortex in patients with β-thalassaemia major
Metafratzi, Z., Argyropoulou, M. I., Kiortsis, D. N., Tsampoulas, C., Chaliasos, N., & Efremidis, S. C. (2001) · British Journal of Radiology · doi:10.1259/bjr.74.881.740407 · Cited by 57
A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis.
Sg, L., Fonseca, T., & Sm, L. (2000) · PubMed · Cited by 57
Transferrin C2, metal binding and Alzheimerʼs disease
van Landeghem, G. F., Sikström, C., Beckman, L. E., Adolfsson, R., & Beckman, L. E. (1998) · Neuroreport · doi:10.1097/00001756-199801260-00001 · Cited by 56
Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis
Forge, J. K., Pedchenko, T. V., & Vine, S. M. L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00512-8 · Cited by 55
Effects of an extracellular metal chelator on neurovascular function in diabetic rats
Cameron, N. E., & Cotter, M. A. (2001) · Diabetologia · doi:10.1007/s001250051669 · Cited by 54
Zhang, Y., Zabad, R., Wei, X., Metz, L., Hill, M. D., & Mitchell, J. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507076411 · Cited by 52
Lehmann, D., Karussis, D. M., Misrachi-Koll, R., Shezen, E., Ovadia, H., & Abramsky, O. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90212-7 · Cited by 51
MR imaging of cerebral cortical involvement in aceruloplasminemia.
Grisoli, M., Piperno, A., Chiapparini, L., Mariani, R., & Savoiardo, M. (2005) · PubMed · Cited by 49
Glycochelates and the etiology of diabetic peripheral neuropathy
Qian, M., & Eaton, J. W. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00262-2 · Cited by 45
Determination of transverse relaxation rate for estimating iron deposits in central nervous system
Hikita, T., Abe, K., Sakoda, S., Tanaka, H., Murase, K., & Fujita, N. (2004) · Neuroscience Research · doi:10.1016/j.neures.2004.09.006 · Cited by 39
Clinical Trials and Financial Reimbursement
Chaturvedi, S. (1998) · Stroke · doi:10.1161/01.str.29.6.1256 · Cited by 39
Hereditary caeruloplasmin deficiency: clinicopathological study of a patient.
Kawanami, T., Kato, T., Daimon, M., Tominaga, M., Sasaki, H., Maeda, K., Arai, S., Shikama, Y., & Katagiri, T. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.5.506 · Cited by 38
Iron and Parkinson's Disease: Chelators to the Rescue?
Levenson, C. W. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.sept.311-313 · Cited by 37
Weilbach, F. X., Chan, A., Toyka, K. V., & Gold, R. (2003) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02344.x · Cited by 37
Use of allopurinol and deferoxamine in cellular protection during ischemia
Soloniuk, D. S., Perkins, E., & Wilson, J. R. (1992) · Surgical Neurology · doi:10.1016/0090-3019(92)90087-4 · Cited by 35
Ferreira, M. D. J., Crouzin, N., Barbanel, G., Cohen‐Solal, C., Récasens, M., Vignes, M., & Guiramand, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.021 · Cited by 31
Willenborg, D. O., Bowern, N. A., Danta, G., & Doherty, P. C. (1988) · Journal of Neuroimmunology · doi:10.1016/0165-5728(88)90020-3 · Cited by 23
Desmethyl tirilazad improves neurologic function after hypoxic ischemic brain injury in piglets
Feng, Y., LeBlanc, M. H., LeBlanc, E. B., Parker, C. C., Fratkin, J. D., Qian, X.-B., Patel, D. M., Huang, M. H., Smith, E. E., & Vig, P. J. S. (2000) · Critical Care Medicine · doi:10.1097/00003246-200005000-00029 · Cited by 21
Shoham, S., & Youdim, M. B. H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.008 · Cited by 20
Andersen, J. K. (2001) · Novartis Foundation symposium · doi:10.1002/0470868694.ch3 · Cited by 18
Hansen, L. A., Willenborg, D. O., & Cowden, W. B. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00104-a · Cited by 17
van der Worp, H. B., Thomas, C. E., Kappelle, L. J., Hoffman, W. P., Wildt, D. J. D., & Bär, P. R. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6968 · Cited by 15
β-amyloid helps to protect neurons from oxidative stress
Bishop, G. M., & Robinson, S. R. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)83347-3 · Cited by 15
Antioxidant responses of cortex neurons to iron loading
Aguirre, P., Mena, N. P., Tapia, V., Rojas‐Fernández, A., Arredondo, M., & Núñez, M. T. (2006) · Biological Research · doi:10.4067/s0716-97602006000100012 · Cited by 10
Medawar, C. (1993) · The Lancet · doi:10.1016/0140-6736(93)91051-m · Cited by 6
(1996) · Pure Amsterdam UMC · doi:10.1002/(sici)1098-1136(199606)17:2
Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Cited by
A guide to assessing cellular senescence in vitro and in vivo
González‐Gualda, E., Baker, A. G., Fruk, L., & Muñoz‐Espín, D. (2021) · The FEBS Journal · doi:10.1111/febs.15570 · Cited by 645
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
Quantitative MR Imaging of Brain Iron: A Postmortem Validation Study
Langkammer, C., Krebs, N., Goessler, W., Scheurer, E., Ebner, F., Yen, K., Fazekas, F., & Ropele, S. (2010) · Radiology · doi:10.1148/radiol.10100495 · Cited by 507
The life, death, and replacement of oligodendrocytes in the adult CNS
McTigue, D. M., & Tripathi, R. B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05570.x · Cited by 455
Metadata
- Authors
- Stankiewicz, J., Panter, S. S., Neema, M., Arora, A., Batt, C. E., & Bakshi, R.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 4
- Issue
- 3
- Pages
- 371-386
- ISSN
- 1878-7479 (ISSN-L)
- OpenAlex
- W2021177193
- Cited by
- 301
- References
- 180
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.